{"nct_id":"NCT03478462","title":"Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-03","start_date":"2019-04-30","start_date_type":"ACTUAL","primary_completion_date":"2025-12-25","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["CLRB"]}